期刊文献+

重组腺病毒人内皮抑素的质量标准研究 被引量:1

Study of Requirements for Quality Control of Recombinant Adenovirus-Mediated Human Endostatin
下载PDF
导出
摘要 目的:建立重组腺病毒人内皮抑素的质量标准和检测方法。方法:PCR法鉴定腺病毒载体的E2B区和插入基因,琼脂糖凝胶电泳检查重组病毒DNA酶切图谱。分光光度法测定病毒颗粒数,TCID50法测定病毒感染滴度。感染人肝癌细胞HepG2测定插入基因的表达量,感染人血管内皮细胞HM2测定表达产物的生物学活性。病毒的纯度分析采用A260/A280比值和HPLC法进行。采用A549细胞进行复制型腺病毒的检测。结果:腺病毒载体E2B区和插入基因PCR扩增结果与理论相符,重组病毒DNA的酶切图谱与标准品一致。原液病毒颗粒数为2.4×1012VP/ml,滴度为1.53×1011IU/ml,比滴度为6.4%IU/VP;成品病毒颗粒数为1.0×1012VP/ml,滴度为3.75×1010IU/ml,比滴度为病3.8%IU/VP.以50MOI重组腺病毒感染HepG2细胞48h后培养上清人内皮抑素表达量为332ng/ml。50MOI重组腺病毒对血管内皮细胞生长的抑制率为55%。A260/A280为1.29,HPLC纯度为99.7%。复制型腺病毒为≤1RCA/3×1010VP。其他各项检测指标均符合规定。结论:建立了重组腺病毒人内皮抑素的质量标准及其检测方法,并用于该产品的质量控制。 Objective:To establish the quality control methods and requirements for recombinant adenovirus-human endostatin products. Methods:E2B region on the adenovirus vector and inserted endostatin gene were identified by PCR. The restricted enzyme digestive map of recombinant virus DNA was analysed by agarose gel eletrophoresis. The number of virus particle and infectious titer were determined by UV and TCID50 method respectively. The expression level of inserted gene was analysed by infection of human HepG2 cell. The potency of expression products was determined by its inhibition effects on the proliferation of human HM2 endothelial cell. The purity of Adv-endostatin was analysed by UV and IE-HPLC. The replication competent virus was detected by A549 cell method. Results:The PCR results of E2B region and endostatin gene on the vector were conformed to theoretics. The restricted enzyme digestive map of detected recombinant virus DNA was identical to that of the reference. The number of virus particle, the infectious titer and the ratio of infectious tiler to virus particle for the bulk were 2.4×1012 VP/ml, 1.53×1011IU/ml, and 6.4% IU/VP respectively. The number of virus particle,the infectious titer and the ratio of infectious titer to virus particle for the finished product were 1. 0×1012VP/ml, 3. 75×1011IU/ml and 3. 8% IU/VP respectively. After the HepG2 cell was infected by recombinant virus for 48 hours,the concentration of endostatin in the culture was 332ng/ml. The inhibition rate of 50 MOI recombinant adenovirus to endothelial cell was 55%. The A260nm/A280nm ratio was 1.29. The purity determined by IE-HPLC was 99.7%. There were less than one replication competent virus within 3×1010 VP recombinanl adenovirus producls. Other items complied with its corresponding requirements. Conclusion:The methods and requirements had been established for quality control of Adv-human endostatin.
出处 《中国肿瘤生物治疗杂志》 CAS CSCD 2005年第2期138-142,共5页 Chinese Journal of Cancer Biotherapy
基金 国家863"十五"计划重大专项(2003 AA223480)
关键词 腺病毒载体 内皮抑素 质量控制 基因治疗 adenovirus vector endostatin quality control gene therapy
  • 相关文献

参考文献8

  • 1O′Reilly MS, Boehm T, Shing Y, et al. Endostatin an endogenous inhibitor of angiogenesis and tumor growth [J]. Cell, 1997, 88(2): 277-285.
  • 2Feldman AL, Restifo NP, Alexander HR, et al. Antiangiogenic gene therapy of cancer utilizing a recombinant adenovirus to elevate systemic endostatin levels in mice[J]. Cancer Res, 2000, 60(6): 1503-1506.
  • 3Sauter BV, Martinet O, Zhang WJ, et al. Adenovirus-mediated gene transfer of endostatin in vivo results in high level of transgene expression and inhibition of tumor growth and metastases[J]. Proc Natl Acad Sci U S A, 2000, 97(9): 4802-4807.
  • 4中国生物标准化委员会.人基因治疗研究和制剂质量控制技术指导原则[M].北京: 国家食品药品监督管理局,2003.2-6.
  • 5林建伟,王军志,饶春明.重组腺病毒人白细胞介素2的质量分析[J].药学学报,2002,37(8):639-643. 被引量:4
  • 6Nyberg-Hoffman C, Shabram P, Li W, et al. Sensitivity and reproducibility in adenoviral infectious titer determination[J]. Nat Med, 1997, 3(7): 808-811.
  • 7高凯,王军志,饶春明,吴小兵.重组腺相关病毒2型/人凝血因子IX的质量研究[J].药学学报,2003,38(9):684-689. 被引量:2
  • 8李永红,王军志,韩春梅,张翊,饶春明.重组人内皮抑素的质控方法研究[J].药学学报,2002,37(10):807-811. 被引量:7

二级参考文献9

  • 1Gu JR. Gene Therapy (基因治疗) [M]. Beijing: Science Press, 2001.48-49.
  • 2Paul DR, Steven CC. Viral vector for gene therapy [J]. Phamacol Ther, 1998,80(1):35-47.
  • 3Cassandra NH, Paul S, Wei L, et al. Sensitivity and reproducibility in adenoviral infectious titer determination [J]. Nat Med, 1997,7(3):808-811.
  • 4Paul WS, Daniel DG, Ann MG, et al. Analytical anion-exchange HPLC of recombinanttype-5 adenoviral particles [J]. Hum Gene Ther, 1997,3(1):453-465.
  • 5Lu SD. Current Protocols for Molecular Biology (现代分子生物学实验技术) [M]. Beijing: Peking Union Medical College and Beijing Medical University Press, 1999.109-115.
  • 6Stewar AK, Lassam NJ, Quirt JC, et al. Adenovecter gene delivery of inteleukin-2 in metastic breast cancer and melanoma: results of a phase 1 clinical trial [J]. Gene Ther, 1999,6(1):350-363.
  • 7The State Pharmacopoeia Commission of the People's Republic of China. Pharmacopoeia of the People's Republic of China (中华人民共和国药典) [M]. Vol II. Beijing: Chemical Industry Press, 2000.App28.
  • 8饶春明,张翊,韩春梅,王军志.重组人白细胞介素-11的胰蛋白酶切肽图分析[J].药学学报,2000,35(5):378-380. 被引量:37
  • 9林建伟,王军志,饶春明.重组腺病毒人白细胞介素2的质量分析[J].药学学报,2002,37(8):639-643. 被引量:4

共引文献10

同被引文献2

引证文献1

二级引证文献5

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部